DFX Intelligence

Allocator Intelligence

The capital-owner graph behind private markets. Who owns the capital, who decides, how much, under what policy, on whose advice, to which managers, and what changed, with a source and a date behind every row. A target is never an actual, a disclosed holding is never an approval, and an estimate says so.

Corporate pension

NEW York Eye and Ear Infirmary Employees' Pension Plan

Corporate pensionNEW York, NY
Assets
$125M
Total assets, Dec 31, 2024 reported
Funded
87.3%
Jan 1, 2024
Private markets target
n/a
policy Dec 31, 2024
Commitments
1
none on the tape
Plan sponsor: NEW York Eye and Ear Infirmary
Allocation policy
Form 5500, as of Dec 31, 2024
Actual allocation lines without a target (as filed)
  • Interest-bearing cash 7.0%
  • Corporate debt instruments (other) 93.0%
Consultants and advisers
3 firms
People
No investment staff or executives have been read for this allocator yet.
Manager roster
1 managers on the commitment tape
From the plan’s own commitment disclosures
From Schedule C (investment management, code 28)
Commitments
1 rows, 0 dated closings
Disclosed holdings (from the plan’s performance or holdings report, as of the report date)
DateFundManagerBucketAmountVintageStatusSource
as of Dec 31, 2022Silchester Int'l Value Equity Trust103 12 ieSilchester International InvestorPublic equity$12.1M heldDisclosed holdingaskebsa.dol.gov
Size and funding
33 readings
Total assets
$125M Dec 31, 2024 reported Form 5500
$134M (2023-12) · $137M (2022-12)
Plan assets
$134M Jan 1, 2024 reported Form 5500
$136M (2023-01) · $173M (2022-01)
Net assets
$125M Dec 31, 2024 reported Form 5500
$134M (2023-12) · $137M (2022-12)
Funded ratio
87.3% Jan 1, 2024 reported Form 5500
85.2% (2023-01) · 113.2% (2022-01)
Funding target
$127M Jan 1, 2024 reported Form 5500
$128M (2023-01) · $125M (2022-01)
Discount rate
5.19% Jan 1, 2024 reported Form 5500
5.32% (2023-01) · 5.48% (2022-01)
Participants
1,397 Jan 1, 2024 reported Form 5500
1,429 (2023-01) · 1,490 (2022-01)
Contributions
$0 Dec 31, 2024 reported Form 5500
$2.7M (2023-12) · $1.3M (2022-12)
Benefits paid
$7.8M Dec 31, 2024 reported Form 5500
$7.7M (2023-12) · $7.4M (2022-12)
Net investment income
$-8.9M Dec 31, 2024 reported Form 5500
$-2.1M (2023-12) · $-36.6M (2022-12)
Investment management fees
$136,748 Dec 31, 2024 reported Form 5500
$179,296 (2023-12) · $816,657 (2022-12)
Form 5500 filings
3 plan years
Plan yearParticipantsAssets (SB market)Funding targetFTAPTotal assets (H)Partnerships / JVMaster trustReal estate
2024 to Dec 31, 20241,397$134M$127M87.3%$125M$0n/an/a
2023 to Dec 31, 20231,429$136M$128M85.2%$134M$912,591n/an/a
2022 to Dec 31, 20221,490$173M$125M113.2%$137M$18.0Mn/an/a
Service providers and investment entities as filed (Schedule C and D, latest year first)
What changed
10 events
  • Dec 31, 2024Manager relationship endedinference
    JP Morgan no longer appears on NEW York Eye and Ear Infirmary Employees' Pension Plan's Schedule C as investment manager (plan year 2024 vs 2023)
    with Jpmorgan Chase Bank, N.A.askebsa.dol.gov
  • Dec 31, 2024Manager relationship endedinference
    Governors Lane no longer appears on NEW York Eye and Ear Infirmary Employees' Pension Plan's Schedule C as investment manager (plan year 2024 vs 2023)
    with Governors Laneaskebsa.dol.gov
  • Jan 1, 2024Funded status changed
    NEW York Eye and Ear Infirmary Employees' Pension Plan funded ratio 85.2% -> 87.3% (2023-01-01 to 2024-01-01)
  • Dec 31, 2023Manager relationship endedinference
    Silchester International no longer appears on NEW York Eye and Ear Infirmary Employees' Pension Plan's Schedule C as investment manager (plan year 2023 vs 2022)
    with Silchester International Investoraskebsa.dol.gov
  • Dec 31, 2023Manager relationship endedinference
    Adage no longer appears on NEW York Eye and Ear Infirmary Employees' Pension Plan's Schedule C as investment manager (plan year 2023 vs 2022)
    with Adageaskebsa.dol.gov
  • Dec 31, 2023Manager relationship endedinference
    Kennedy Capital Management no longer appears on NEW York Eye and Ear Infirmary Employees' Pension Plan's Schedule C as investment manager (plan year 2023 vs 2022)
    with Kennedy Capital Managementaskebsa.dol.gov
  • Dec 31, 2023Manager relationship endedinference
    Davidson Kempner no longer appears on NEW York Eye and Ear Infirmary Employees' Pension Plan's Schedule C as investment manager (plan year 2023 vs 2022)
    with Davidson Kempner Capital Mgmt LPaskebsa.dol.gov
  • Dec 31, 2023Manager relationship endedinference
    Select Equity Fund LP no longer appears on NEW York Eye and Ear Infirmary Employees' Pension Plan's Schedule C as investment manager (plan year 2023 vs 2022)
    with Select Equity Fund LPaskebsa.dol.gov
  • Jan 1, 2023Funded status changed
    NEW York Eye and Ear Infirmary Employees' Pension Plan funded ratio 113.2% -> 85.2% (2022-01-01 to 2023-01-01)
  • Jan 1, 2023Assets changed
    NEW York Eye and Ear Infirmary Employees' Pension Plan plan assets $173M -> $136M (-21.1%, 2022-01-01 to 2023-01-01)
Board record: approvals, recommendations, searches, terminations and re-up prospects for this system.
Provenance
Identifiers: EIN-PN 135562304-001
Cross-graph: no entry on another DFX graph
First observed Sep 15, 2026, last observed Sep 15, 2026. Classification confirmed. Every row above carries its source; a reported figure is the subject’s own, a derived one is arithmetic on reported figures, an estimated one is a model or a survey imputation and is never summed into a headline.